Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Bayer

    Tag: bayer

    You Searched For "Bayer"
    Bayer, Johnson and Johnson win reversal of 28 million dollars verdict in Xarelto lawsuit

    Bayer, Johnson and Johnson win reversal of 28 million dollars verdict in Xarelto lawsuit

    Ruby Khatun Khatun11 Jan 2018 10:15 AM IST
    A Pennsylvania state court judge on Tuesday overturned a $27.8 million jury award to an Indiana couple who accused Bayer AG and Johnson and Johnson of...
    Bayer sticks to bone metastasis drug estimate after setback

    Bayer sticks to bone metastasis drug estimate after setback

    Ruby Khatun Khatun6 Dec 2017 9:15 AM IST
    BERLIN: Bayer is sticking to its peak sales estimate for bone metastasis drug Xofigo despite a setback in a late-stage drug trial, the head of the...
    Bayer taps Nestle nutrition head to lead consumer care unit

    Bayer taps Nestle nutrition head to lead consumer care unit

    Ruby Khatun Khatun18 Nov 2017 9:30 AM IST
    FRANKFURT: Bayer has hired the head of Nestle's baby food business to run its embattled consumer health division, replacing Erica Mann in March next...
    Novartis posts eye drug data amid play for Eylea

    Novartis posts eye drug data amid play for Eylea's turf

    Ruby Khatun Khatun14 Nov 2017 9:45 AM IST
    ZURICH: Novartis's bid to move in on Bayer's and Regeneron's eye-drug turf was buoyed on Friday by data showing patients on the Swiss drugmaker's new...
    Exelixis drug improves overall survival in liver cancer patients

    Exelixis drug improves overall survival in liver cancer patients

    Ruby Khatun Khatun21 Oct 2017 9:12 AM IST
    Exelixis Inc's drug to treat a type of liver cancer improved overall survival in patients in a late-stage study that prompted an independent expert...
    Bayer, Johnson and Johnson in frame for bigger anti-clotting market opportunity

    Bayer, Johnson and Johnson in frame for bigger anti-clotting market opportunity

    Ruby Khatun Khatun28 Aug 2017 1:05 PM IST
    FRANKFURT: Bayer and Johnson & Johnson's blockbuster clot prevention drug Xarelto was shown to cut the risk of potentially deadly strokes and...
    Delhi HC allows Natco, Alembic to Export Rivaroxaban of Bayer

    Delhi HC allows Natco, Alembic to Export Rivaroxaban of Bayer

    savita thakur thakur10 March 2017 9:45 AM IST
    NEW DELHI: In a recent order passed by Delhi High Court, the court has granted the permission to Indian pharmaceuticals companies, Alembic and Natco...
    Bayer applies for Regorafenib authorization to treat liver cancer

    Bayer applies for Regorafenib authorization to treat liver cancer

    supriya kashyap kashyap8 Nov 2016 11:56 AM IST
    German drugmaker Bayer said it submitted an application to have its cancer drug Regorafenib approved for the second-line treatment of liver cancer...
    Prev

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok